« Back to report listing

OVERVIEW

Cost: FREE

PUBLICATION DATE:SEP 2010

Therapeutic class:Oncology

Number of Pages:22

FREE DOWNLOAD

Please enter your information below to access the free download of our Bladder Cancer report.

We respect your privacy and will never share your email address with any person or organization.

light report icon

Bladder Cancer

Strategic Analysis of the Therapeutics Market

REPORT SUMMARY

In this report PharmaPeek presents a concise analysis of the global bladder cancer therapeutics market. This analysis includes challenges, factors driving growth, and revenue forecasts from 2010-2013. Competitive opportunities are identified, as well as novel strategies to exploit these opportunities and overcome industry challenges.


TABLE OF CONTENTS

  • Chapter 1: Introduction & Summary of Key Findings
    • Executive Summary
    • Research Scope & Segmentation
    • Overview of the Bladder Cancer Therapeutics Market
  • Chapter 2: Market Overview
    • Current Therapeutic Options – Superficial Bladder Cancer
    • Current Therapeutic Options – Invasive Bladder Cancer
    • Future Therapeutic Approaches
  • Chapter 3: Market Engineering Measurement Analysis
    • Competitive Analysis
    • Pipeline Analysis
    • Market Revenue Forecasts
    • Pricing and Reimbursement Issues
  • Chapter 4: Market Adoption Factor Analysis: Global Bladder Cancer Therapeutics Market
    • Challenges for the Bladder Cancer Therapeutics Market
    • Market Drivers
    • Market Restraints
  • Chapter 5: Trends Analysis & Market Engineering Recommendations
    • Snapshot of Current & Future Trends
    • Strategic Recommendations
  • Chapter 6: Database of Key Industry Participants
    • Contact Details

COMPANIES DISCUSSED

  • Bristol-Myers Squibb
  • Eli Lilly
  • Sanofi Pastuer
  • Anthra
  • Spectrum
  • Bioniche
  • Pierre Fabre Medicament S.A.
  • Pfizer
  • Medac GmbH
  • Intas
  • Kyowa Hakko Kogyo
  • Bedford
  • Amgen
  • MD Organon
  • Photocure
  • Roche
  • Transgene

DRUGS DISCUSSED

  • Gemcitabine
  • Paclitaxel
  • Mitomycin C
  • Cisplatin
  • Platinol AQ
  • Paraplatin
  • Carbolplatin
  • Mutamycin
  • Adriamycin
  • Thioplex
  • Thiotepa
  • Epirubicin
  • Tice BCG
  • Theracycs Bacillus Calmette-Guerin
  • Cytoxan
  • Blenoxane
  • Taxol
  • Gemzar
  • OncoTICE
  • Valrubicin
  • EOquin
  • Urocidin
  • Methotrexate
  • Vinblastine
  • Doxorubicin/Adraimycin
  • Cyclophosphamide
  • Ifosfamide
  • 5-fluorouracil
  • Vindesine Alkaloid
  • Mitoxzantrone
  • Oxaliplatin
  • Vinflunine
  • Aldesleukin
  • KLH
  • Taxol
  • Herceptin
  • Javlor
  • Celebrex
  • Fenretinide
  • MVAC
  • Tykerb
  • Hexvix
  • MAGE-3